Illumina

Yahoo Finance • 3 days ago

Personalized Medicine Market Competitive Landscape Report 2025: Company Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033

Company Logo Personalized Medicine Market Poised for Tremendous Growth by 2033The global personalized medicine market, valued at approximately US$ 585.53 billion in 2026, is projected to soar to nearly US$ 1.00 trillion by 2033. A report... Full story

Yahoo Finance • 3 days ago

Cancer Diagnostics Market Competitive Landscape Report 2025: Key Players Analysis, Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033

Company Logo The Cancer Diagnostics Market is set to grow from USD 197.7 billion in 2025 to USD 345.57 billion by 2033, driven by a 7.23% CAGR. Factors like rising cancer incidence, technological advancements in diagnostics, and the impor... Full story

Yahoo Finance • 3 days ago

Lung Cancer Diagnostics Competitive Landscape Report 2025: Key Players Analysis, Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033

Company Logo The Lung Cancer Diagnostics Market is set to expand from US$ 21.74 billion in 2025 to US$ 38.00 billion by 2033, growing at a CAGR of 7.23%. Major growth drivers include increased public access facilities, rise in ambulance s... Full story

Yahoo Finance • 3 days ago

Next Generation Sequencing Market Competitive Landscape Report 2025 Featuring Top Players - Thermo Fisher Scientific, Pacific Biosciences, Illumina, Roche

Company Logo The Next-Generation Sequencing (NGS) market is set to surge from $14.79 billion in 2025 to $56.25 billion by 2033, with a robust CAGR of 18.17%. Key drivers include advancements in sequencing technologies, applications in gen... Full story

Yahoo Finance • 3 days ago

Genetic Testing Market Competitive Landscape Report 2025: Key Players Analysis, Profiles, Strategic Developments, Sustainability, Launches, Mergers, Product Innovations, Revenue Insights

Company Logo The genetic testing market is set to reach USD 49.72 billion by 2033, expanding at a CAGR of 9.79% from USD 23.55 billion in 2025. Key growth drivers include oncology, rare disease diagnostics, and prenatal testing, underscor... Full story

Yahoo Finance • 7 days ago

Genomics Stocks That Deserve a Place in Your Portfolio in 2026

An updated edition of the Jan. 6, 2026, article. Genomics is the comprehensive study of genomes—the complete set of deoxyribonucleic acid (DNA) within an organism. Rapid scientific progress in this field has intensified interest among pha... Full story

Yahoo Finance • 18 days ago

Precision Medicine Analysis Report 2026: A $237.28 Billion Market by 2031 - Strategic Pharma-Big-Tech Alliances Speeding Precision Drug Discovery

Dublin, Feb. 09, 2026 (GLOBE NEWSWIRE) -- The "Precision Medicine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" report has been added to ResearchAndMarkets.com's offering. The Precision Medicine... Full story

Yahoo Finance • 21 days ago

Could Nvidia Be the Best Way to Play the AI Boom in 2026?

Key Points Nvidia is a tech juggernaut and the most valuable company in the world right now. Despite OpenAI and Alphabet looking to move away from its hardware, Nvidia's chips remain coveted the world over. The company is still growing... Full story

Yahoo Finance • 21 days ago

Stocks Rebound on Positive Tech Earnings

The S&P 500 Index ($SPX) (SPY) today is up +1.20%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +1.48%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +1.26%.  March E-mini S&P futures (ESH26) are up +1.21%, and March E-mini Nasdaq fu... Full story

Yahoo Finance • 22 days ago

Illumina outlines 2026 revenue guidance of $4.5B–$4.6B while advancing clinical growth and multiomics strategy

Earnings Call Insights: Illumina (ILMN) Q4 2025 MANAGEMENT VIEW * CEO Jacob Thaysen announced that Q4 results "exceeded expectations, capped off with 20% growth in our clinical consumables revenue ex-China, reflecting execution across... Full story

Yahoo Finance • 25 days ago

AbbVie Inc. (ABBV): A Bull Case Theory

We came across a bullish thesis on AbbVie Inc. on Disruptive Analytics ’ Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on ABBV. AbbVie Inc.'s share was trading at $223.01 as of January 30th. ABBV’s trailin... Full story

Yahoo Finance • 3 months ago

Analysts See Big Upside in Catalyst Pharmaceuticals, Inc. (CPRX)

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is among the cheap healthcare stocks to buy heading into 2026. As of December 7, Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is a consensus Buy with all seven analysts covering it assigning it... Full story

Yahoo Finance • 3 months ago

Wix Stock Tumbles 50% in One Year — But Is Vibe-Coding AI Platform Base44 the Reason This Fund Is Doubling Down?

Key Points New York City-based Senvest Management increased its holdings in Wixcom by 447,765 shares during the third quarter. The move helped increase the overall position value by about $118.7 million from the prior period. Senvest now... Full story

Yahoo Finance • 3 months ago

Why One Fund Dumped $74 Million of Bank OZK Stock Despite a Record $180.5 Million Earnings

Key Points New York City-based Senvest Management sold nearly 1.6 million shares of Bank OZK in the third quarter. The move marked a full exit, reducing exposure by approximately $74.4 million. The position previously accounted for 2.5% o... Full story

Yahoo Finance • 3 months ago

This Fintech Stock Is Down 70% — But a Hedge Fund Just Boosted Its $66 Million Stake

Key Points New York City-based Senvest Management increased its stake in nCino by nearly 2.4 million shares during the third quarter. The overall position value grew by $63.8 million from quarter to quarter. Following the transaction, Sen... Full story

Yahoo Finance • 3 months ago

EPAM Stock Is Down 15% This Past Year — But This Fund Is Betting $146 Million on a Turnaround

Key Points New York City-based Senvest Management added 524,798 shares of EPAM in the third quarter. The move helped boost the overall position value by $67.6 million. Senvest reported holding 968,404 EPAM shares valued at $146 million as... Full story

Yahoo Finance • 3 months ago

DNA Diagnostics Market Projected to Surge by 66% to USD 21.69 Billion by 2030

Company Logo The DNA Diagnostics Market is set to surge from USD 13.07 billion in 2024 to USD 21.69 billion by 2030, growing at a CAGR of 8.81%. Key trends driving this growth include the emergence of liquid biopsies, the rise of direct-t... Full story

Yahoo Finance • 3 months ago

The Ensign Group, Illumina, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a fur... Full story

Yahoo Finance • 3 months ago

LLY joins $1T club but doesn't feature in SA's top 10 large-cap healthcare stocks

[Lilly Biotechnology Center in San Diego, California, USA.] JHVEPhoto Eli Lilly (LLY [https://seekingalpha.com/symbol/LLY]) officially joined the elite group of U.S. companies valued at more than $1T on Friday, becoming the tenth American... Full story

Yahoo Finance • 4 months ago

Closing Bell Movers: Amazon soars to all-time highs on earnings

In the opening hour of the evening session, U.S. equity futures are notably higher, with S&P 500 up 0.5% and Nasdaq 100 contracts up 1.0%.  In commodities, WTI Crude Oil is little changed just above $60 per barrel while precious metals are... Full story